Sintx Technologies (SINT) to Release Quarterly Earnings on Monday

Sintx Technologies (NASDAQ:SINT) is expected to be announcing its results before the market opens on Monday, March 30th. Analysts expect the company to announce earnings of ($0.55) per share and revenue of $0.30 million for the quarter.

Sintx Technologies (NASDAQ:SINT) last released its quarterly earnings data on Wednesday, March 18th. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.56. Sintx Technologies had a negative return on equity of 218.25% and a negative net margin of 775.12%.The firm had revenue of $0.29 million during the quarter, compared to analyst estimates of $0.30 million.

Sintx Technologies Stock Performance

Shares of Sintx Technologies stock opened at $2.49 on Monday. Sintx Technologies has a 52-week low of $1.71 and a 52-week high of $6.78. The company’s 50 day moving average price is $3.09 and its 200-day moving average price is $3.59. The stock has a market capitalization of $9.16 million, a price-to-earnings ratio of -0.44 and a beta of 0.66.

Hedge Funds Weigh In On Sintx Technologies

An institutional investor recently raised its position in Sintx Technologies stock. Geode Capital Management LLC lifted its stake in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,624 shares of the company’s stock after buying an additional 9,265 shares during the quarter. Geode Capital Management LLC owned about 0.72% of Sintx Technologies worth $103,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 18.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Ascendiant Capital Markets dropped their price target on shares of Sintx Technologies from $25.00 to $16.00 and set a “buy” rating for the company in a research report on Monday, December 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $16.00.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.